Revvity (UK) Limited

The large node is Revvity (UK) Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 8

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

From Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.

• UKHSA Diagnostics & Research Open Framework Buyer: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency £5,200,000,000 2026-09-03 Source: Find a Tender

  UKHSA Diagnostics & Research Open Framework (DRF) This is a competitive tendering procedure pursuant to the Notices published on the Find a Tender Central Digital Platform. UK02 Preliminary Market Engagement October 25 2025/S 000-069968, PI…

  Framework
• Maintenance contract for - Chemagic 360- Buyer: Leeds Teaching Hospitals NHS Trust £28,014 2026-05-20 CPV 50420000 Source: Contracts Finder

  Maintenance contract for - Chemagic 360-D(96h) Contract Reference Number: 2023/S 000-028831 Service package Platinum URN *** CPQ 17792 PTH 26 ** Additional information: Maintenance contract for - Chemagic 360-D(96h) Contract Refe…
• Provision of Assay Kits for SCID Evaluation: EONIS-Q Buyer: NHS England £949,937 2026-04-22 CPV 85100000 Source: Contracts Finder

  his request is for re-procurement same scope for 18 months, via a compliant Direct Ward National framework for the EONIS Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot for Severe Combin…
• Provision of Assay Kits for SCID & SMA In-Service Evaluations - EONIS-Q Revvity Buyer: NHS England £4,074,117 2026-03-25 CPV 33100000 Source: Contracts Finder

  EONIS-Q Assay methodology, as part of the delivery and implementation of the ongoing NHS Newborn Blood Spot in-service evaluation (ISE) for Severe Combined Immuno-Deficiency (SCID) in 4 Screening laboratories, with the addition of the ISE f…
• Purchase Revvity Chemagic Viral DNA/RNA 300 Kit H96 consumables Buyer: UK Health Security Agency £53,498 2026-03-02 CPV 33696500 Source: Contracts Finder

  Purchase Revvity Chemagic Viral DNA/RNA 300 Kit H96 consumables via the National Microbiology Framework.
• Commercial Kit for screening for hereditary tyrosinemia type 1 (HT1) Buyer: NHS England £1,677,290 2025-03-31 CPV 33696200 Source: Contracts Finder

  Newborn Blood Spot screening (NBS) is a national programme offered to all babies born in the UK, and it currently screens for 9 rare but potentially lethal conditions. The blood spot screening sample is taken from the baby's heel collected …
• Neonatal software support Buyer: Manchester University NHS Foundation Trust £423,090 2025-02-28 CPV 48000000 Source: Contracts Finder

  MFT procurement for Neonatal software support contract under NHS Supply Chain framework
• Supply, installation, and commissioning of Liquid Scintillation Counters Buyer: UK Atomic Energy Authority Value not published Date not published Source: Find a Tender

  The UKAEA Health Physics Laboratory provides analysis of tritium contaminated smears, air samples and liquids from facilities across the Culham site. In addition, gaseous stack discharge samples are also processed. Tritium is measured via L…
• Supply and delivery of a Tri-Carb liquid scintillation counter Buyer: Nuclear Restoration Services Limited Value not published Date not published Source: Find a Tender

  A competitive contract has been awarded by Nuclear Restoration Services Limited (Dounreay) for the supply and delivery of a Tri-Carb liquid scintillation counter (LSC)
• Capital Purchase of Genetic Screening Processor and Panthera Punch Buyer: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) Value not published Date not published CPV 33100000 Source: Find a Tender

  The Cardiff and Vale University Health Board have a requirement to replace the current Newborn Screening Analysers used for CHT and CF screening. The current equipment is at the end of life, as well as nearing discontinuation. Replacement…
• Urgent Award - haematological screening Buyer: NHS England Value not published Date not published CPV 85111810 Source: Find a Tender

  Mass haematological screening of prisoners in light of suspected outbreaks
• Quote ref: 40914110 Signature Plus Service plan Buyer: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST Value not published Date not published Source: Find a Tender

  1604 - Plus Service plan for SN: 20241969 & SN: 20241971 - Chemagic 360 x 2. Genetics. Our Contact Oliver Wright.
• Signature Plus Service plan Buyer: CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST Value not published Date not published Source: Find a Tender

  1604 - Signature Plus Service plan for SN: 20241969 & SN: 20241971 - Chemagic 360 x 2. Genetics.

About

Incorporated

30/04/1999

Ownership

Group

1. Revvity (UK) Limited is controlled by Revvity (UK) Holdings Limited
   Evidence

   active 75-100% shares, 75-100% voting, appoints directors · notified 2022-05-16 · source: Companies House PSC register

Ultimately controlled by Revvity (UK) Holdings Limited.

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Sources

Official record from Companies House. Governance Register calculates the connections.